Clinical Trials in Houston

Showing 12341-12360 of 15,366 trials

WITHDRAWNPhase 1< 1 mile

Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia

NCT00732186

The purpose of the study is to assess the safety of ipilimumab and dasatinib combination therapy in patients with CML

Leukemia, Myeloid, Chronic

Bristol-Myers SquibbStarted Aug 2009

Houston, Texas, United States

TERMINATEDPhase 2< 1 mile

Atacicept in Subjects With Optic Neuritis

NCT00624468

This study was intended to evaluate the efficacy, safety and tolerability of atacicept compared to placebo and to explore the neuroprotective effect of atacicept as assessed by OCT in subjects with ON as CIS. The study was randomized. Study medication was administered via subcutaneous (under the skin) injections.

Optic Neuritis

EMD Serono34 participantsStarted Jun 2008

Birmingham, Alabama, United States • Aurora, Colorado, United States • Fairfield, Connecticut, United States +25 more locations

Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia

Atacicept in Subjects With Optic Neuritis

Find Trials by Condition in Houston

Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Timing of Morning Rounds for Postpartum Hospitalized Women

BATTLE Program: Sorafenib in Patients With NSCLC

Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma

BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)

Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

AqueSys Microfistula Implant in Refractory Glaucoma

A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C

Relapse Prevention Study in Newly Abstinent Smokers

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine

Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

Safety of Gadovist in Renally Impaired Patients